MA-EXAGRID
22.12.2020 14:02:15 CET | Business Wire | Press release
ExaGrid ® , the industry’s only Tiered Backup Storage solution, today announced that the company had a successful year despite the worldwide struggles associated with the COVID-19 pandemic.
“We are grateful to our customers, reseller partners, and alliance partners who have worked with us to make 2020 such a successful year, in spite of the adversity that we have all faced during the pandemic. We are hopeful that in 2021 that there will be some return to normalcy and look forward to more in-person meetings and events,” said Bill Andrews, President and CEO of ExaGrid. “In the meantime, we have been fortunate that ExaGrid’s industry-leading customer support model already featured remote installation and support, so we have been able to continue our no-contact installation for the safety of our staff and customers without interruption.”
Some of ExaGrid’s major highlights in 2020 include:
- Strong growth in Q1 to Q3, especially in the Americas and EMEA, which included a record number of six and seven-figure purchases for both new and existing customers, with another impressive quarter expected for Q4.
- Continued expansion into the Middle East region, adding new territory managers in Israel, Saudi Arabia and the United Arab Emirates, growing the global sales team, which now covers of 30 countries, with planned expansion to grow to 50 countries over the next two years.
- The release of Software Version 6.0, which included a streamlined navigation experience, user interface improvements, security enhancements, and most notably, the Retention Time-Lock for Ransomware Recovery, making ExaGrid the only backup storage system on the market to offer a non-network-facing tier with immutable objects and delayed deletes for ransomware recovery solution.
-
Recognition for its Tiered Backup Storage appliances, earning the following awards in the fall of 2020:
-
Network Computing Awards
- Company of the Year
- Hardware Product of the Year
-
Storage Awards “The Storries XVII”
- Enterprise Backup Hardware Vendor of the Year
- Storage Performance Optimisation Company of the Year
-
SDC Awards
- Storage Company of the Year
- Storage Hardware Innovation of the Year
- Vendor Channel Program of the Year
-
Network Computing Awards
ExaGrid’s Tiered Backup Storage offers a disk-cache Landing Zone for backup and restore performance and is tiered to a long-term retention repository for cost efficient storage with data deduplication as well as a scale-out storage architecture that scales as data grows. ExaGrid offers the best of both worlds by pairing the fastest backup and restore performance with the lowest cost long-term retention storage.
About ExaGrid
ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, and scale-out architecture. ExaGrid’s Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The retention repository offers the lowest cost for long-term retention. ExaGrid’s scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and product obsolescence. ExaGrid’s Retention Time-Lock is the only backup storage solution with a non-network facing tier, immutable objects and delayed deletes for ransomware recovery. Visit us at exagrid.com
or connect with us on LinkedIn
. See what our customers have to say about their own ExaGrid experiences, and learn why they now spend significantly less time on backup, in our customer success stories
.
ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005068/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 15:00:00 CEST | Press release
New Washington State facility provides capacity to manufacture more than 30,000 radars annually, strengthening the U.S. defense industrial base As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructu
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 15:00:00 CEST | Press release
Analysis of more than 1,200 production cloud environments provides a first-hand view into how organizations are embedding AI into business-critical workflows, exposing new security risks that traditional controls weren't built to address. Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become ope
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 15:00:00 CEST | Press release
Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai's health system network Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's co
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
